Cosmos Health forecasts over $6 million in annual U.S. revenue from Oliv18 within 12-18 months

Reuters2026/08/24 19:47

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Cosmos Health forecast Oliv18 to add over $6 million in annual U.S. revenue within 12-18 months.
Outlook implies about $4.3 million in gross profit, based on an expected gross margin of about 72%.
Rollout starts with direct-to-consumer e-commerce, followed by expansion into selected retail channels.
Model assumes pricing, sales volumes, repeat purchases, distribution growth tied to execution of commercialization plans.
Target markets: U.S. cardiovascular supplements $2.11 billion in 2024, projected $3.27 billion by 2030; antioxidants $1.66 billion in 2025, projected $3.18 billion by 2035.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cosmos Health Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202608241540OMX_____CNEWS_EN_GNW9815111_en) on August 24, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Cosmos Health forecasts over $6 million in annual U.S. revenue from Oliv18 within 12-18 months

You may also like

Crypto prices